A New Possible Cut-Off of Cytokeratin 19 MRNA Copy Number by OSNA in the Sentinel Node of Breast Cancer Patients to Avoid Unnecessary Axillary Dissection: A 10-Year Experience in a Tertiary Breast Unit
Overview
Authors
Affiliations
(1) Background: The main discriminant in breast cancer prognosis is axillary lymph node status. In a select cohort of patients, axillary lymph node dissection (ALND) may be safely spared. This study aimed to determine a new possible cut-off of cytokeratin (CK) 19 mRNA copy number in the SLN to predict cases at high risk of positive ALND. (2) Methods: Clinical records of 1339 patients were retrospectively reviewed and were separated into two groups according to the axillary status (negative: ALNs- and positive ALNs+). Receiver operative characteristic (ROC) curves were used to identify a new optimal cut-off of CK19 mRNA copy number in SLN; (3) Results: Large tumor size and high grade were found mostly in ALNs+. Results from the ROC analyses, with an AUC of 82.1%, identified a new cut-off (9150 CK19 mRNA copies) showing 94% sensitivity, 67.3% specificity, 61.2% positive, and 95.3% negative predictive values; (4) OSNA remains the most-important intra-operative tool to identify patients who can benefit from ALND but with the traditional cut-off, many patients undergo needless ALND. The results of the present study suggest a new cut-off helpful to personalize surgical treatment and avoid unnecessary invasive procedures.
Application of the OSNA Technique (One-Step Nucleic Acid Amplification Test) in Breast Cancer.
Sychowski G, Romanowicz H, Smolarz B Int J Mol Sci. 2025; 26(2).
PMID: 39859370 PMC: 11766269. DOI: 10.3390/ijms26020656.
Fan Y, Li J, Zhu D, Zhu H, Zhao Y, Zhu X BMC Surg. 2023; 23(1):209.
PMID: 37495945 PMC: 10369839. DOI: 10.1186/s12893-023-02101-8.